OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader
Giuseppe Ermondi, Diego García Jiménez, Matteo Rossi Sebastiano, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 272-272
Open Access | Times Cited: 14

Showing 14 citing articles:

Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
Edward Price, Manuel Weinheimer, Alexey Rivkin, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5683-5698
Closed Access | Times Cited: 23

Exploring the chemical space of orally bioavailable PROTACs
Giulia Apprato, Vasanthanathan Poongavanam, Diego García Jiménez, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103917-103917
Open Access | Times Cited: 15

Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs
Diego García Jiménez, Maura Vallaro, Matteo Rossi Sebastiano, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10681-10693
Open Access | Times Cited: 18

Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders
Corentin Bouvier, Rachel Lawrence, Francesca Cavallo, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 578-578
Open Access | Times Cited: 5

IMHB-Mediated Chameleonicity in Drug Design: A Focus on Structurally Related PROTACs
Diego García Jiménez, Matteo Rossi Sebastiano, Maura Vallaro, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11421-11434
Closed Access | Times Cited: 5

Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access

Discovery of Potent SOS1 PROTACs with Effective Antitumor Activities against NCI-H358 Tumor Cells In Vitro/In Vivo
Xudong Pang, Dawei Cui, Binhua Lv, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1563-1579
Closed Access | Times Cited: 4

Computational methods and key considerations for in silico design of proteolysis targeting chimera (PROTACs)
Amr E. Abbas, Fei Ye
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134293-134293
Closed Access | Times Cited: 3

Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2

Closing the Design–Make–Test–Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability
Zulma Santisteban Valencia, Jennifer Kingston, Filip Miljković, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20242-20257
Closed Access

Flexible Fluorine-Thiol Displacement Stapled Peptides with Enhanced Membrane Penetration for the Estrogen Receptor/Coactivator Interaction
Robert Maloney, Samuel L. Junod, Kyla M. Hagen, et al.
Journal of Biological Chemistry (2024), pp. 107991-107991
Open Access

Impact of Linker Composition on VHL PROTAC Cell Permeability
Yordanos Esubalew Abeje, Lianne H. E. Wieske, Vasanthanathan Poongavanam, et al.
Journal of Medicinal Chemistry (2024)
Open Access

Page 1

Scroll to top